Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon

American Journal of Clinical Pathology

Volumn 121, Issue 6, 2004, Pages 884-892

  Chu, Peiguo G ^a   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Hepatocyte paraffin 1; Immunohistochemistry; Intestinal metaplasia; Signet ring cell carcinoma

Indexed keywords

ANTIBODY; CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN RECEPTOR; HEPATOCYTE PARAFFIN 1; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST; BREAST CARCINOMA; CELL NUCLEUS; COLON; COLON CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH; STOMACH CARCINOMA; TUMOR LOCALIZATION;

EID: 2442677662     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/A09ERYMFR64NERDW     Document Type: Article

References (38)

1. Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma. Cancer. 1982;50:775-781.
2. Connelly JH, Robey-Cafferty SS, el-Naggar AK, et al. Exophytic signet-ring cell carcinoma of the colorectum [letter]. Arch Pathol Lab Med. 1991;115:427.
3. Frost AR, Terahata S, Yeh IT, et al. The significance of signet ring cells in infiltrating lobular carcinoma of the breast. Arch Pathol Lab Med. 1995;119:64-68.
4. Liu SM, Chen DR. Signet-ring cell carcinoma of the breast. Pathol Int. 2000;50:67-70.
5. Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol. 1991;48:28-31.
6. Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993;114:637-641.
7. Klein M, Sherlock P. Gastric and colonic metastases from breast cancer. Am J Dig Dis. 1972;17:881-886.
8. Gagnon Y, Tetu B. Ovarian metastases of breast carcinoma: a clinicopathologic study of 59 cases. Cancer. 1989;64:892-898.
9. Esaki Y, Hirayama R, Hirokawa K. A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer. 1990;65:2086-2090.
10. Amorn Y, Knight WA Jr. Primary linitis plastica of the colon: report of two cases and review of the literature. Cancer. 1978;41:2420-2425.
11. Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
12. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Applied Immunohistochem. 1995;3:99-107.
13. Ajioka Y, Allison LJ, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol. 1996;49:560-564.
14. Biemer-Huttmann AE, Walsh MD, McGuckin MA, et al. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem. 1999;47:1039-1048.
15. Moll R, Mitze M, Frixen UH, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993;143:1731-1742.
16. Lehr HA, Folpe A, Yaziji H, et al. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol. 2000;114:190-196.
17. Mallo GV, Rechreche H, Frigerio JM, et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox: down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer. 1997;74:35-44.
18. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310.
19. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993;143:1050-1054.
20. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978-988.
21. Chu PG, Jiang Z, Weiss LM. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27:952-959.
22. Castro CY, Moran CA, Fleider DG, et al. Primary signet ring cell adenocarcinomas of the lung: a clinicopathological study of 15 cases. Histopathology. 2001;39:397-401.
23. Merchant SH, Amin MB, Tamboli P, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001;25:1515-1519.
24. Torbenson M, Dhir R, Nangia A, et al. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature. Mod Pathol. 1998;11:552-559.
25. Wahed A, Connelly J, Reese T. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diagn Pathol. 2002;6:349-351.
26. Chan JK, Wong CS. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Adv Anat Pathol. 2001;8:165-172.
27. Etzell JE, Devries S, Chew K, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol. 2001;32:292-296.
28. Fricke E, Keller G, Becker I, et al. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma. Int J Cancer. 2003;104:60-65.
29. Tot T. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract. APMIS. 2000;108:467-472.
30. Cameron BL, Butler JA, Rutgers J, et al. Immunohistochemical determination of the estrogen receptor content of gastrointestinal adenocarcinomas. Am Surg. 1992;58:758-760.
31. Yokozaki H, Takekura N, Takanashi A, et al. Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis. Virchows Arch A Pathol Anat Histopathol. 1988;413:297-302.
32. Raju U, Ma CK, Shaw A. Signet ring variant of lobular carcinoma of the breast: clinical and immunological study. Mod Pathol. 1993;6:516-520.
33. Goldstein NS, Long A, Kuan SF, et al. Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl Immunohistochem Molecul Morphol. 2000;8:183-188.
34. Matsukita S, Nomoto M, Kitajima S, et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology. 2003;42:26-36.
35. Alpaugh ML, Tomlinson JS, Kasraeian S, et al. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene. 2002;21:3631-3643.
36. Kuan SF, Montag AG, Hart J, et al. Differential expression of mucin genes in mammary and extramammary Paget's disease. Am J Surg Pathol. 2001;25:1469-1477.
37. Rahn JJ, Dabbagh L, Pasdar M, et al. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91:1973-1982.
38. Baldus SE, Monig SP, Hanisch FG, et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma. Histopathology. 2002;40:440-449.